Jefferies Maintains Buy on Cross Country Healthcare, Lowers Price Target to $32
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Brian Tanquilut maintains a 'Buy' rating on Cross Country Healthcare (NASDAQ:CCRN) but lowers the price target from $40 to $32.
October 05, 2023 | 6:13 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Jefferies analyst maintains a 'Buy' rating on Cross Country Healthcare but lowers the price target from $40 to $32.
The news is directly related to Cross Country Healthcare (CCRN). While the 'Buy' rating is maintained, the lowering of the price target might indicate a potential slowdown in growth or increased risk, which could have a neutral to slightly negative impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100